These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23073666)

  • 1. Effect of the fluoroquinolone antibacterial agent DX-619 on the apparent formation and renal clearances of 6β-hydroxycortisol, an endogenous probe for CYP3A4 inhibition, in healthy subjects.
    Imamura Y; Murayama N; Okudaira N; Kurihara A; Inoue K; Yuasa H; Izumi T; Kusuhara H; Sugiyama Y
    Pharm Res; 2013 Feb; 30(2):447-57. PubMed ID: 23073666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6β-Hydroxycortisol is an endogenous probe for evaluation of drug-drug interactions involving a multispecific renal organic anion transporter, OAT3/SLC22A8, in healthy subjects.
    Imamura Y; Tsuruya Y; Damme K; Heer D; Kumagai Y; Maeda K; Murayama N; Okudaira N; Kurihara A; Izumi T; Sugiyama Y; Kusuhara H
    Drug Metab Dispos; 2014 Apr; 42(4):685-94. PubMed ID: 24487120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of the CYP3A5*3 and CYP3A4*1G polymorphisms with the pharmacokinetics of oral midazolam and the urinary 6β-hydroxycortisol/cortisol ratio as markers of CYP3A activity in healthy male Chinese.
    Chan SW; Xiao Y; Hu M; Yin OQ; Chu TT; Fok BS; Lee VH; Tomlinson B
    J Clin Pharm Ther; 2016 Oct; 41(5):552-8. PubMed ID: 27511886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of 6β-hydroxycortisol, 6β-hydroxycortisone, and a combination of the two as endogenous probes for inhibition of CYP3A4 in vivo.
    Peng CC; Templeton I; Thummel KE; Davis C; Kunze KL; Isoherranen N
    Clin Pharmacol Ther; 2011 Jun; 89(6):888-95. PubMed ID: 21490593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in urinary excretion of 6beta-hydroxycortisol in common marmosets as a marker of hepatic CYP3A induction.
    Totsuka S; Watanabe T; Koyanagi F; Tanaka K; Yasuda M; Manabe S
    Arch Toxicol; 1999; 73(4-5):203-7. PubMed ID: 10463384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separation and quantitative determination of 6α-hydroxycortisol and 6β-hydroxycortisol in human urine by high-performance liquid chromatography with ultraviolet absorption detection.
    Shibasaki H; Okamoto S; Inoue R; Okita M; Yokokawa A; Furuta T
    Anal Bioanal Chem; 2012 Mar; 402(9):2945-52. PubMed ID: 22318698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals.
    Galteau MM; Shamsa F
    Eur J Clin Pharmacol; 2003 Dec; 59(10):713-33. PubMed ID: 14605790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The variability of liver graft function and urinary 6beta-hydroxycortisol to cortisol ratio during liver regeneration in liver transplant recipients.
    Kishino S; Ogawa M; Takekuma Y; Sugawara M; Shimamura T; Furukawa H; Todo S; Miyazaki K
    Clin Transplant; 2004 Apr; 18(2):124-9. PubMed ID: 15016124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
    Ushiama H; Echizen H; Nachi S; Ohnishi A
    Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of CYP3A activity in humans using three different parameters based on endogenous cortisol metabolism.
    Luo X; Li XM; Hu ZY; Cheng ZN
    Acta Pharmacol Sin; 2009 Sep; 30(9):1323-9. PubMed ID: 19701237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women.
    Benzi JRL; Moreira FL; Marques MP; Duarte G; Suarez-Kurtz G; Lanchote VL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 May; 1144():122074. PubMed ID: 32247187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of taurine and L-carnitine on 6 β-hydroxycortisol/cortisol ratio in human urine of healthy volunteers.
    Makhova AA; Shikh EV; Bulko TV; Sizova ZM; Shumyantseva VV
    Drug Metab Pers Ther; 2019 Oct; 34(3):. PubMed ID: 31603853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of fluoroquinolone-induced elevation in serum creatinine levels: a case of drug-endogenous substance interaction involving the inhibition of renal secretion.
    Imamura Y; Murayama N; Okudaira N; Kurihara A; Okazaki O; Izumi T; Inoue K; Yuasa H; Kusuhara H; Sugiyama Y
    Clin Pharmacol Ther; 2011 Jan; 89(1):81-8. PubMed ID: 21124314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Nonmetabolized β-Blocker Nadolol Is a Substrate of OCT1, OCT2, MATE1, MATE2-K, and P-Glycoprotein, but Not of OATP1B1 and OATP1B3.
    Misaka S; Knop J; Singer K; Hoier E; Keiser M; Müller F; Glaeser H; König J; Fromm MF
    Mol Pharm; 2016 Feb; 13(2):512-9. PubMed ID: 26702643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma 6β-hydroxycortisol to cortisol ratio as a less invasive cytochrome P450 3A phenotyping method.
    Hirano R; Yokokawa A; Furihata T; Shibasaki H
    Br J Clin Pharmacol; 2024 Apr; 90(4):1016-1026. PubMed ID: 38102865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure.
    Komazawa H; Yamaguchi H; Hidaka K; Ogura J; Kobayashi M; Iseki K
    J Pharm Sci; 2013 Mar; 102(3):1086-94. PubMed ID: 23280877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary 6beta-hydroxycortisol/17-hydroxycorticosteroids ratio as a measure of hepatic CYP3A4 capacity after enzyme induction.
    Konishi H; Tanaka K; Minouchi T; Yamaji A
    Ann Clin Biochem; 2004 Jul; 41(Pt 4):335-7. PubMed ID: 15298747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid chromatographic determination of urinary 6beta-hydroxycortisol to assess cytochrome p-450 3A activity in HIV positive pregnant women.
    Homma M; Beckerman K; Hayashi S; Jayewardene AL; Oka K; Gambertoglio JG; Aweeka FT
    J Pharm Biomed Anal; 2000 Sep; 23(4):629-35. PubMed ID: 10975239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of Endogenous Compounds Applicable to Drug-Drug Interaction Studies Involving the Renal Organic Anion Transporters, OAT1 and OAT3, in Humans.
    Tsuruya Y; Kato K; Sano Y; Imamura Y; Maeda K; Kumagai Y; Sugiyama Y; Kusuhara H
    Drug Metab Dispos; 2016 Dec; 44(12):1925-1933. PubMed ID: 27638508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mirogabalin, a novel α
    Yamamura N; Mikkaichi T; Itokawa KI; Hoshi M; Damme K; Geigner S; Baumhauer C
    Xenobiotica; 2022; 52(9-11):997-1009. PubMed ID: 36170033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.